Welcome New Council Members
We rely on our advisory breast cancer research council for guidance in setting our research priorities, providing effective outreach to CBCRP stakeholders, and making grant-funding decisions. The council is comprised of advocates, scientists, clinicians, nonprofit health representatives, and industry representatives. All of these individuals have provided insightful vision that has shaped the CBCRP into what it is today. Council members serve a three-year term, so each year introduces new changes that ensure that our program continues to develop and grow. Led by a newly-elected chair and vice-chair, Lisa Wanzor and Amy Kyle, respectively, we and the council welcome five new members (who appear below on pages 7 and 8).
Crystal D. Crawford, Esq., serves as
CEO of the California
Black
Women’s Health Project, where she
performs legislative, educational, and |
Diane Griffiths currently serves
as Chief Counsel to the California State
Assembly Rules Committee. In 1995-
1996, Griffiths served as Chief of Staff
to Assemblywoman Barbara Friedman,
the author of the legislation that created |
Gordon Parry, Ph.D., is currently
Head of the Cancer Research Department
at Berlex Biosciences in Richmond,
California. He has focused his research
on utilizing genomics technologies to find
new targets for drug development and in
discovering small molecule and antibodybased
drugs. Prior to joining Berlex, Dr.
Parry was head of cancer gene therapy |
Klaus Porzig, M.D., received
both his undergraduate and Doctor of
Medicine degrees at Stanford University,
then completed his internship at
University of California, San Francisco.
He completed his residency in internal
medicine and clinical fellowship in
medical oncology at Stanford University.
He was also a research fellow in the |
Catherine
Quinn is the Executive
Director of the California Health Collaborative.
She has provided steadfast
leadership to community health efforts |
|





